March 19, 2026
Federal cannabis rescheduling moved from speculation to executive action in December 2025. President Trump signed Executive Order 14370, directing the Attorney General to expedite moving marijuana from Schedule I to Schedule III. The cannabis industry responded with optimism, but the distance between an executive order and a final rule is where compliance teams either prepare or stumble.
Informational only. This content is not legal or tax advice.
On December 18, 2025, the White House issued Executive Order 14370, titled "Increasing Medical Marijuana and Cannabidiol Research." The order directed the Attorney General to initiate or expedite rulemaking to reschedule marijuana from Schedule I to Schedule III under the Controlled Substances Act.
What it did not do: move marijuana to Schedule III. An executive order is a directive, not a final agency action. The DEA must complete a formal rulemaking process that includes a public comment period, review of administrative law judge findings, and publication of a final rule in the Federal Register. That process was already underway since May 2024, but had been complicated by legal appeals and procedural challenges.
As of March 2026, reports indicate a descheduling commission may also be in development, which would add another layer of policy deliberation. Operators should track both the rulemaking and any commission activity, because one could influence or delay the other.
Section 280E of the Internal Revenue Code disallows ordinary business deductions for any business that traffics in Schedule I or Schedule II controlled substances. For cannabis operators, this means effective tax rates can reach 70 to 80 percent of gross margin, a burden that compresses working capital and distorts financial planning.
If marijuana moves to Schedule III, 280E no longer applies. Operators could deduct rent, payroll, marketing, insurance, and other normal business expenses. The Congressional Budget Office has scored the revenue implications, and the financial relief would be substantial across the industry.
But timing matters. Until a final rule takes effect, 280E remains the law. Filing positions that assume rescheduling before the rule is published create audit exposure. The IRS has not issued guidance suggesting any interim relief, and practitioners across the industry are urging caution.
As Kristin Kowalski, CPA, noted in MG Magazine in March 2026: "Cannabis operators should model post-280E scenarios now but avoid tax or structural changes until rescheduling is final."
A common misconception is that Schedule III status will resolve cannabis banking challenges. It will not, at least not completely.
Major banks continue to view cannabis proceeds as carrying significant compliance risk under federal law. The SAFER Banking Act remains the clearest path to broad banking access, and as of early 2026 it has not passed Congress. Even with Schedule III status, cannabis businesses would still require Bank Secrecy Act compliance, suspicious activity report filing obligations, and enhanced due diligence from financial institutions.
According to ArentFox Schiff's 2026 cannabis outlook, ACH transactions are projected to reach 42 percent of cannabis payments in 2026, up from 28 percent in 2025. Progress is real, but it is incremental and driven by state-level banking partnerships rather than federal policy changes.
Operators expanding their banking relationships now should prepare for a paradox identified by ArentFox Schiff: Schedule III status may actually increase scrutiny around recordkeeping, anti-money laundering controls, and beneficial ownership transparency. Banks and payment partners will likely require deeper documentation before onboarding cannabis clients.
The gap between signal and outcome is exactly where compliance discipline matters most. Operators cannot control the federal timeline, but they can control their readiness. The following actions build optionality without creating premature exposure.
If 280E disappears, your finance team will need to immediately begin claiming deductions that were previously disallowed. That requires a chart of accounts that already separates cost of goods sold from operating expenses with the granularity to support both regimes.
Review account structures now. Ensure that rent, utilities, payroll, marketing, professional services, and insurance are coded to distinct accounts rather than lumped into broad categories. If your current structure cannot support a clean transition, restructure it while the current rules still apply. It is easier to refine account coding during normal operations than during a scramble triggered by a rule change.
Build two financial models: one that assumes 280E continues through fiscal year 2027, and one that assumes it ends mid-year. Test cash flow, tax liability, and working capital under each. Identify which expenses you would begin deducting immediately and what documentation you would need to support those deductions under audit.
This is not speculative planning. It is scenario analysis that any well-run business would do when facing a material change in its operating environment.
Whether or not rescheduling arrives on a predictable timeline, the trend toward broader banking access is clear. Operators who build strong compliance documentation now will be positioned to access better banking terms faster.
Assemble a package that includes: current state licenses and renewal status, beneficial ownership disclosures, seed-to-sale tracking reports showing inventory reconciliation, tax compliance history, anti-money laundering policies, and a compliance officer designation with documented training records.
Executive orders generate headlines. Proposed rules, comment periods, and Federal Register publications generate legal effect. Operators should monitor the DEA rulemaking docket directly and subscribe to updates from the Office of Information and Regulatory Affairs, which reviews significant rules before publication.
Key milestones to watch include: publication of a proposed rule with a comment period, any administrative law judge hearings, publication of a final rule, and the effective date specified in the final rule. The effective date, not the publication date, is when the legal change takes effect.
Some operators are already exploring entity restructuring, merger terms, or acquisition pricing that assumes rescheduling. This creates risk. If final rules differ from expectations, or if legal challenges delay implementation, contracts and structures built on assumptions may produce unintended consequences.
The Ropes and Gray analysis from January 2026 identified significant hurdles remaining in the rulemaking process, including pending legal challenges that could delay or modify the outcome. Build flexibility into agreements rather than embedding assumptions about federal scheduling status.
Federal rescheduling is more likely now than at any point in cannabis history. But likelihood is not certainty, and a directive is not a final rule. Operators who prepare their financial systems, documentation, and banking relationships now will be positioned to move quickly when the rules change. Those who restructure prematurely based on expectations may find themselves exposed if timelines shift.
The disciplined path is clear: model both outcomes, prepare for both timelines, and act only when the legal basis is final.
